Stephane Milano

Stephane Milano has a diverse work experience in the field of pharmaceuticals and research. Starting in 2013, Stephane served as a Chief Scientific Officer (CSO) at WIL Research until 2016. Following this, Stephane worked at MILLENDO THERAPEUTICS as the VP of Preclinical Development & Pharmacology from 2018 to 2019. In 2020, Stephane joined Amolyt Pharma as a Senior R&D Advisor until 2022. Currently, Stephane holds the position of Chief Scientific Officer (CSO) at Product Safety Labs, starting in 2022.

Stephane Milano has a PhD in Pharmacology-Physiology, specializing in the regulation of the autonomic nervous system. Stephane obtained this degree from Aix-Marseille University, where they studied from 1990 to 1993.